1122597-86-7 Usage
Uses
Used in Pharmaceutical Industry:
2-Boc-7-formyl-1,2,3,4-tetrahydropyrrolo[3,2,1-jk][1,4]benzodiazepine is used as a reactant in the synthesis of hydroxamic acid compounds. These hydroxamic acid compounds serve as histone deacetylase (HDAC) inhibitors, which play a crucial role in the regulation of gene expression. By inhibiting HDACs, these compounds can modulate cellular processes such as cell proliferation, differentiation, and apoptosis, making them potential therapeutic agents for various diseases, including cancer.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-Boc-7-formyl-1,2,3,4-tetrahydropyrrolo[3,2,1-jk][1,4]benzodiazepine can be employed as a building block or intermediate for the preparation of more complex molecules. Its unique structure and functional groups make it a valuable starting material for the development of novel compounds with diverse applications, such as pharmaceuticals, agrochemicals, and advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1122597-86-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,2,5,9 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1122597-86:
(9*1)+(8*1)+(7*2)+(6*2)+(5*5)+(4*9)+(3*7)+(2*8)+(1*6)=147
147 % 10 = 7
So 1122597-86-7 is a valid CAS Registry Number.
1122597-86-7Relevant academic research and scientific papers
HDAC INHIBITORS
-
Page/Page column 57; 60, (2009/04/25)
The present invention provides hydroxamic acid compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising the hydroxamic acid compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a compound of the present invention.
